سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

The first experience of stem cell labeling in Iran using 111In- Oxine [Persian]

Publish Year: 1386
Type: Journal paper
Language: English
View: 470

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دانلود نمایند.

Export:

Link to this Paper:

Document National Code:

JR_IRJNM-15-2_009

Index date: 15 April 2020

The first experience of stem cell labeling in Iran using 111In- Oxine [Persian] abstract

  Introduction: The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. Stem cell therapy seems to be a new treatment option for some diseases. So, tracking the distribution of stem cells is crucial to their therapeutic use. Based on this fact we labeled human mesenchymal stem cells (MSCs) with 111In- oxine for the first time in our country. The aim of this study was to investigate the possibility of stem cell labeling in Iran. In addition the researchers assessed the cell viability, specific activity and labeling efficiency after labeling. Methods:  After culturing mesenchymal stem cells (MSCs), for radio-labeling, the sample (which contained 1×106MSCs) were mixed, and suspended with 50 µCi 111In-oxine, and then incubated for 20 min at the room temperature. The cells were then washed with normal saline twice to remove the free 111In. Results:  The labeling efficiency, specific activity and cell viability was 70.6%, 31.70 µCi/106 and 100%, respectively. Conclusion: It seems that, this method is practical and easily applicable with acceptable efficiency and specific activity in our laboratory settings using pharmaceutical produced in Iran.

The first experience of stem cell labeling in Iran using 111In- Oxine [Persian] Keywords:

The first experience of stem cell labeling in Iran using 111In- Oxine [Persian] authors

Ali Gholamrezanezhad

Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Bagheri

Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran

Mehdi Mohammadnezhad

Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran

Sahar Mirpour

Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran